Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients

Objective: The aim of this study was to explore the tolerance, variability, and pharmacokinetics (PK) of albumin-bound paclitaxel (QL, HR, ZDTQ) among Chinese breast cancer patients.Methods: Three randomized, open-label, two-period crossover bioequivalence studies were conducted with albumin-bound p...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Qingmei Li, Hong Zhang, Xiaoxue Zhu, Chengjiao Liu, Min Wu, Cuiyun Li, Xiaojiao Li, Lei Gao, Yanhua Ding
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2018-11-01
Colecção:	Frontiers in Pharmacology
Assuntos:	cancer albumin-bound paclitaxel bioequivalence variability
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fphar.2018.01372/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!